Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NEUTROPHIL FLUORESCENCE AS AN EARLY BIOMARKER OF SEPSIS SEVERITY IN THE EMERGENCY DEPARTMENT

NCT07585942 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT07585942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07585942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NEUTROPHIL FLUORESCENCE AS AN EARLY BIOMARKER OF SEPSIS SEVERITY IN THE EMERGENCY DEPARTMENT
Lead sponsor
University Hospital, Strasbourg, France
Phase
Observational
Overall status
Not yet recruiting
Start date
May 12, 2026
Completion date
December 12, 2027
Enrollment
492 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disseminated intravascular coagulation (dic), sepsis, septic shock